Latest News by Industry
LEVERKUSEN, Germany--(BUSINESS WIRE)--Oct 5, 2022--
Bayer has completed the sale of its Environmental Science Professional business to the international private equity firm Cinven, after the two companies had entered into a corresponding agreement in March. The conditions for closing the transaction – including the receipt of regulatory approval – have now been met. The purchase price for the business, which generated sales of approximately 600 million euros in 2021, amounts to 2.6 billion U.S. dollars.
“We thank the employees of Environmental Science Professional for their many years of commitment and the associated success of Bayer. In Cinven, we have found a strong new owner with a firm commitment to the long-term growth potential of the business and to its people,” said Rodrigo Santos, member of the Board of Management of Bayer AG and head of the Crop Science Division. “At the same time, we can concentrate on our core agricultural business and the successful implementation of our growth strategy in the Crop Science Division.” Bayer will use the net proceeds from the transaction to reduce its net financial debt.
The divested business is set to operate as an independent company called Envu. The business is a global leader offering solutions to control pests, disease and weeds in non-agricultural areas such as vector control, professional pest management, vegetation management, forestry, and turf and ornamentals. It is headquartered in Cary, North Carolina, United States, and is active in over 100 countries. Nearly 900 employees in total will transfer from Bayer to Envu.
“Envu is a global leader in a highly attractive and critical industry. We thank Bayer for the trust they have placed in Cinven and plan to build on the strong foundations established by Bayer by significantly investing in it,” said Pontus Pettersson, Partner at Cinven. “Cinven is excited to build an independent, focused company and is well positioned to continue to drive innovation and accelerate growth, including the delivery of digital and data-enabled solutions, and to extend the product portfolio further by creating innovative and sustainable solutions for its customers.”
About Envu
Envu was founded in 2022, a new company built on years of Bayer experience, for the sole purpose of advancing healthy environments for everyone, everywhere. Envu offers dedicated services in: Professional Pest Management, Forestry, Ornamentals, Golf, Industrial Vegetation Management, Lawn & Landscape, Mosquito Management, and Range & Pasture. Across each of its lines of business, Envu focuses its work in chemistry and beyond, collaborating with customers to come up with innovative solutions that will work today and well into the future. Envu’s portfolio consists of over 180 trusted and well-known brands. The company employs nearly 900 people and operates in more than 100 countries with four global innovation hubs. For additional information, visit the Envu website.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. R&D expenses before special items amounted to 5.3 billion euros. For more information, go to www.bayer.com.
About Cinven
Cinven is a leading international private equity firm focused on building world-class global companies. Its funds invest in six key sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials and TMT (Technology, Media and Telecommunications). Cinven has offices in London, New York, Frankfurt, Paris, Milan, Madrid, Guernsey and Luxembourg. Cinven takes a responsible approach towards its portfolio companies, their employees, suppliers, local communities, the environment and society. www.cinven.com
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
View source version on businesswire.com:https://www.businesswire.com/news/home/20221004005783/en/
CONTACT: Contact for media inquiries:
Bayer AG
Dr. Rolf Ackermann, phone +49 214 30-41782
Email:rolf.ackermann@bayer.comEnvu
Jennifer Poore, Tel. +1 919 475-5814
E-Mail:jennifer.poore@envu.comContact for investor inquiries:
Bayer Investor Relations Team, phone +49 214 30-72704
Email:ir@bayer.com
www.bayer.com/en/investors/ir-teamFind more information atwww.bayer.com.
Follow us on Twitterhttps://twitter.com/bayer
KEYWORD: GERMANY EUROPE
INDUSTRY KEYWORD: HEALTH OTHER HEALTH FITNESS & NUTRITION OTHER SCIENCE GENERAL HEALTH RESEARCH SCIENCE
SOURCE: Bayer
Copyright Business Wire 2022.
PUB: 10/05/2022 09:30 AM/DISC: 10/05/2022 09:32 AM
http://www.businesswire.com/news/home/20221004005783/en